(MENAFN- Khaleej Times) Abu Dhabi-headquartered PureHealth has completed the subscription process for its initial public offering (IPO) on the Abu Dhabi Securities Exchange (ADX), witnessing staggering demand from investors in the UAE and the region.
The company's final offer price was set at Dh3.26 per share - with 1.11 billion shares offered, representing 10 per cent of the healthcare platform's share capital worth Dh3.62 billion.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
The largest healthcare platform in the Middle East's IPO registered significant demand from investors resulting in multiple oversubscriptions.
The subscription period, which commenced on December 6 and closed on Monday, saw total gross demand cross the Dh265-billion mark.
The professional subscribers' tranche attracted a demand of Dh186 billion, reflecting an oversubscription level of 54 times. Meanwhile, the retail offering witnessed tremendous appetite from investors, accumulating demand of over Dh78 billion, marking an oversubscription level of 483 times.
Farhan Malik, founder and managing director of PureHealth, said:“This is a resounding endorsement of the market's confidence in our achievements, the management's execution capability, and our vision for growth. The IPO unlocks PureHealth's credentials in transforming healthcare systems, underscoring our commitment to shaping the future of healthcare through continuous innovation and an unwavering pursuit of excellence, where we take Pure Health from Abu Dhabi to the World.”
Trading on the ADX is set to start on December 20 with a market capitalisation at the time of listing estimated to reach Dh36.2 billion.
PureHealth has a diverse portfolio comprising more than 25 hospitals, 100 clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, and procurement.
ALSO READ:
UAE: Abu Dhabi's PureHealth IPO fully subscribed on opening day
Why and how can you invest in the UAE stock markets
Dubai Taxi Company shares soar almost a fifth on market debut
MENAFN12122023000049011007ID1107582899
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.